Cyanocobalamin Encyclopedia — Scientific Background

What Is Cyanocobalamin?

Cyanocobalamin (CAS 68-19-9), also known as vitamin B12, cobalamin, or α-(5,6-dimethylbenzimidazolyl)cobamide cyanide, is a water-soluble vitamin with the molecular formula C₆₃H₈₈CoN₁₄O₁₄P and a molecular weight of 1355.37 g/mol. The compound is a complex cob(III)alamin in which cobalt is positioned in the center of a planar corrin tetrapyrrole ring and bound axially to a 5,6-dimethylbenzimidazole moiety and a cyano group. Cyanocobalamin occurs as dark red crystals or amorphous or crystalline red powder that is odorless, very hygroscopic, and sensitive to light.

The Forms of Vitamin B12

Vitamin B12 exists in several chemical forms, each with distinct properties and biological roles:

Cyanocobalamin — The most stable and widely used synthetic form, with a cyano group attached to the central cobalt ion. It is converted in the body to the active coenzyme forms. Cyanocobalamin is the reference standard form used in pharmacopoeias worldwide.

Methylcobalamin — The predominant form in human plasma and the cofactor for methionine synthase. It is directly utilized without enzymatic conversion.

Adenosylcobalamin — The mitochondrial form that serves as a cofactor for L-methylmalonyl-CoA mutase.

Hydroxocobalamin — A naturally occurring form that is the most stable cobalamin and is used therapeutically for cyanide poisoning.

Cyanocobalamin is preferred in supplements and pharmaceutical preparations due to its superior stability, established safety profile, and cost-effectiveness.

Physiological Functions of Cyanocobalamin

Cyanocobalamin is converted in the body to methylcobalamin and adenosylcobalamin, which are critical for numerous physiological functions:

• Red Blood Cell Formation — Vitamin B12 is essential for normal red blood cell formation and helps prevent megaloblastic anemia.

• Neurological Function — Vitamin B12 supports neurological function and myelin sheath maintenance, contributing to normal nervous system function and cognitive health.

• Homocysteine Regulation — Methylcobalamin is a cofactor for methionine synthase, which converts homocysteine to methionine, supporting healthy homocysteine metabolism.

• DNA Synthesis — Vitamin B12 is required for DNA synthesis and cellular division.

• Energy Metabolism — Vitamin B12 contributes to normal energy-yielding metabolism and helps reduce tiredness and fatigue.

• Immune Function — Vitamin B12 supports normal immune system function.

The Bioavailability Challenge

Despite its essential physiological functions, conventional oral vitamin B12 presents significant bioavailability challenges. The primary absorption mechanism for vitamin B12 is dependent on gastric intrinsic factor (GIF), a glycoprotein secreted by parietal cells. The saturation of GIF receptors in the terminal ileum imposes a biological ceiling on absorption, often rendering high-dose oral supplementation inefficient for patients with compromised gastric mucosa or intrinsic factor deficiency. Passive diffusion across the intestinal epithelium accounts for only approximately 1% to 2% of total absorption when pharmacological doses are administered.

These limitations have driven the development of advanced delivery systems, including liposomal encapsulation. Liposomal B12 achieves significantly higher AUC and Cmax by utilizing alternative absorption routes such as membrane fusion and lymphatic transport, effectively bypassing the GIF-dependent absorption pathway.

Liposomal Cyanocobalamin

Liposomal encapsulation of cyanocobalamin provides a fundamentally different delivery mechanism from conventional forms. The phospholipid bilayer surrounds the cyanocobalamin molecule, forming a protective shell that enhances stability, bioavailability, and cellular uptake. This delivery system:

• Achieves up to 4 times higher bioavailability compared to non-liposomal pill forms in human clinical study

• Leads to a 42% increase in plasma cobalamin levels versus only 10% for the non-liposomal comparator

• Bypasses the GIF-dependent absorption pathway, enabling efficient absorption in individuals with compromised gastric mucosa

• Demonstrates rapid serum repletion in geriatric populations, with up to 270% increase in serum B12 levels

• Protects cyanocobalamin from light-induced degradation and pH-dependent breakdown

Clinical Evidence

Human Bioavailability Study — Randomized Controlled Trial

A randomized, controlled, two-group human clinical study enrolled 11 metabolically healthy volunteers to compare the bioavailability of liquid Liposomal vitamin B12 versus non-Liposomal vitamin B12 in pill form. Participants received a single 2,500 μg dose of either formulation, and plasma cobalamin and holo-transcobalamin levels were measured over time. The liposomal formulation demonstrated up to 4 times higher bioavailability than the non-liposomal pill form and led to a 42% increase in plasma cobalamin levels compared to only 10% for the non-liposomal comparator. The liposomal formulation also maintained elevated plasma levels throughout the entire study period, demonstrating sustained highest concentrations during daily supplementation.

Oral Cyanocobalamin-Loaded liposomes — Preclinical Study

A study published in the Journal of the Iwate Medical Association evaluated oral cyanocobalamin-loaded nanoparticles for intestinal absorption. The study aimed to develop an oral nanoparticle formulation that could enable vitamin B12 absorption even in the absence of gastric intrinsic factor. Liposomes were selected as the nanoparticle carrier, and cyanocobalamin-loaded liposomes were orally administered to mice. The results demonstrated that the liposomal formulation achieved significantly higher blood concentrations compared to aqueous solution administration, even in normal mice with functional intrinsic factor. This indicates that liposomal encapsulation provides superior translocation across the intestinal barrier regardless of intrinsic factor status.

Rapid Serum Repletion in Geriatric Populations

Clinical evidence indicates rapid serum repletion in geriatric populations, with up to 270% increase in serum B12 levels following liposomal B12 supplementation. Improved nerve conduction velocity has also been observed in patients with diabetic neuropathy.

Safety and Regulatory

Cyanocobalamin has a well-established safety profile. It is a water-soluble vitamin, and excess amounts are excreted in the urine. No tolerable upper intake level (UL) has been established for vitamin B12 due to its low toxicity.

Regulatory Status:

• United States — Cyanocobalamin is regulated as a dietary supplement ingredient and pharmaceutical agent. It is Generally Recognized As Safe (GRAS) for use in food and dietary supplements. It is monographed in the USP with an assay specification of NLT 96.0% and NMT 100.5% on dried basis.

• European Union — Cyanocobalamin is authorized as a vitamin and mineral substance which may be used in the manufacture of food supplements. It is monographed in the European Pharmacopoeia.

• Japan — Cyanocobalamin is monographed in the Japanese Pharmacopoeia (JP) with an assay specification of 96.0%–100.5%. It is approved as a pharmaceutical ingredient (JAN/INN).

• Global Standards — Cyanocobalamin is monographed in the USP, European Pharmacopoeia, British Pharmacopoeia, Japanese Pharmacopoeia, and International Pharmacopoeia.

Precautions: Cyanocobalamin is generally well tolerated. Individuals with known hypersensitivity to cobalt or cobalamin derivatives should avoid supplementation. Cyanocobalamin may interact with certain medications, including chloramphenicol, proton pump inhibitors, and metformin. Pregnant or lactating women and children should consult a healthcare professional before use.

Testing protocols must adhere to international standards including USP, European Pharmacopoeia, and FAO/WHO Codex Alimentarius. Formulators should verify local regulatory requirements prior to market entry.

This product is intended for research, nutraceutical, and functional food applications. Not intended to diagnose, treat, cure, or prevent any disease.

99$/KG